These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 27005822)

  • 21. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
    Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
    Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells.
    López-González R; Kunckles P; Velasco I
    Cell Transplant; 2009; 18(10):1171-81. PubMed ID: 19660174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The alteration of serine transporter activity in a cell line model of amyotrophic lateral sclerosis (ALS).
    Lee NY; Kim Y; Ryu H; Kang YS
    Biochem Biophys Res Commun; 2017 Jan; 483(1):135-141. PubMed ID: 28043791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation.
    Koh SH; Kim Y; Kim HY; Cho GW; Kim KS; Kim SH
    Eur J Neurosci; 2007 Apr; 25(7):1923-30. PubMed ID: 17439481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective Effect of Human Adipose Stem Cell-Derived Extract in Amyotrophic Lateral Sclerosis.
    Jeon GS; Im W; Shim YM; Lee M; Kim MJ; Hong YH; Seong SY; Kim M; Sung JJ
    Neurochem Res; 2016 Apr; 41(4):913-23. PubMed ID: 26646002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
    Wootz H; Weber E; Korhonen L; Lindholm D
    Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc pre-treatment enhances NMDAR-mediated excitotoxicity in cultured cortical neurons from SOD1(G93A) mouse, a model of amyotrophic lateral sclerosis.
    Nutini M; Frazzini V; Marini C; Spalloni A; Sensi SL; Longone P
    Neuropharmacology; 2011 Jun; 60(7-8):1200-8. PubMed ID: 21056589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of a cell model of ALS disease: Golgi apparatus disruption occurs independently from apoptosis.
    Gomes C; Palma AS; Almeida R; Regalla M; McCluskey LF; Trojanowski JQ; Costa J
    Biotechnol Lett; 2008 Apr; 30(4):603-10. PubMed ID: 18004513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of motor neuron degeneration by novel iron chelators in SOD1(G93A) transgenic mice of amyotrophic lateral sclerosis.
    Wang Q; Zhang X; Chen S; Zhang X; Zhang S; Youdium M; Le W
    Neurodegener Dis; 2011; 8(5):310-21. PubMed ID: 21346313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct roles for motor neuron autophagy early and late in the SOD1
    Rudnick ND; Griffey CJ; Guarnieri P; Gerbino V; Wang X; Piersaint JA; Tapia JC; Rich MM; Maniatis T
    Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8294-E8303. PubMed ID: 28904095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice.
    Staats KA; Van Helleputte L; Jones AR; Bento-Abreu A; Van Hoecke A; Shatunov A; Simpson CL; Lemmens R; Jaspers T; Fukami K; Nakamura Y; Brown RH; Van Damme P; Liston A; Robberecht W; Al-Chalabi A; Van Den Bosch L
    Neurobiol Dis; 2013 Dec; 60():11-7. PubMed ID: 23969236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of calpain-1 in the early phase of experimental ALS.
    Stifanese R; Averna M; De Tullio R; Pedrazzi M; Milanese M; Bonifacino T; Bonanno G; Salamino F; Pontremoli S; Melloni E
    Arch Biochem Biophys; 2014 Nov; 562():1-8. PubMed ID: 25151305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
    Han Y; Ripley B; Serada S; Naka T; Fujimoto M
    PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent blockade of free radical and microsomal prostaglandin E synthase-1-mediated PGE2 production improves safety and efficacy in a mouse model of amyotrophic lateral sclerosis.
    Shin JH; Lee YA; Lee JK; Lee YB; Cho W; Im DS; Lee JH; Yun BS; Springer JE; Gwag BJ
    J Neurochem; 2012 Sep; 122(5):952-61. PubMed ID: 22537108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
    Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
    Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death.
    Dewil M; dela Cruz VF; Van Den Bosch L; Robberecht W
    Neurobiol Dis; 2007 May; 26(2):332-41. PubMed ID: 17346981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic background effects on disease onset and lifespan of the mutant dynactin p150Glued mouse model of motor neuron disease.
    Heiman-Patterson TD; Blankenhorn EP; Sher RB; Jiang J; Welsh P; Dixon MC; Jeffrey JI; Wong P; Cox GA; Alexander GM
    PLoS One; 2015; 10(3):e0117848. PubMed ID: 25763819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcitonin gene-related peptide expression levels predict motor neuron vulnerability in the superoxide dismutase 1-G93A mouse model of amyotrophic lateral sclerosis.
    Ringer C; Weihe E; Schütz B
    Neurobiol Dis; 2012 Jan; 45(1):547-54. PubMed ID: 21964254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis.
    Bordet T; Buisson B; Michaud M; Drouot C; Galéa P; Delaage P; Akentieva NP; Evers AS; Covey DF; Ostuni MA; Lacapère JJ; Massaad C; Schumacher M; Steidl EM; Maux D; Delaage M; Henderson CE; Pruss RM
    J Pharmacol Exp Ther; 2007 Aug; 322(2):709-20. PubMed ID: 17496168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.